• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant

Valeant

Page 7 of 12
Senate Banking Committee Hearing with Janet Yellen
RetailThe Fed Meets and China’s Li Talks–5 Things to Know Today
By Geoffrey SmithMarch 16, 2016
Berkshire Hathaway Annual Meeting
FinanceWhy Bill Ackman Ought to Buy Warren Buffett a Coke
By Jen WiecznerMarch 15, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceBill Ackman Is Running Out of Options with Valeant
By Stephen GandelMarch 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant’s Shares Are Having An Epically Bad Day
By Jen WiecznerMarch 15, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
HealthValeant Just Slashed Its Profit Guidance
By Reuters and Fortune EditorsMarch 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceHere’s What Valeant’s Earnings Tell Us About the Future of the Drug Maker
By Jen WiecznerMarch 14, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceValeant Shareholders Push for More Details About CEO’s Illness
By ReutersMarch 13, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
HealthCongress Wants to Know Why Valeant Won’t Hand Over Documents
By ReutersMarch 10, 2016
Key Speakers At The 20th Annual Sohn Investment Conference
FinanceBill Ackman Says a Management Change May Soon Be Necessary at Valeant
By ReutersMarch 8, 2016
Hillary Clinton Holds Post-Super Tuesday Rally In NYC
FinanceThis Is Why Hillary Clinton’s Attack on Drug Price Hikes Doesn’t Add Up
By Jen WiecznerMarch 4, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant’s CEO Called Analysts To Ask For More Time
By Lucinda ShenMarch 2, 2016
hillary clinton
HealthHillary Clinton Says She’s ‘Going After’ Valeant In New Campaign Ad
By Sy MukherjeeMarch 1, 2016
Hedge fund manager Bill Ackman
FinanceBill Ackman Says Valeant Will Be Fine
By Lucinda ShenMarch 1, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
LeadershipValeant CEO Michael Pearson to Return from Medical Leave
By ReutersFebruary 28, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
LeadershipValeant’s CEO Is Feeling Better, But Board May Not Want Him Back
By Jen WiecznerFebruary 26, 2016
1...
  • 5
  • 6
  • 7
  • 8
  • 9
...12
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.